About ScottCare
Products

TeleRehab™ Advantage
NICORE™ ECP
Outcomes
Accessories
Transtelephonic Monitoring

Service & Support
News
Contact Us
NICORE™ Home | What is ECP? | What Happens During ECP Treatment? | Proven Treatment | Procedure Description | ScottCare's Commitment | Clinical Considerations | ECP Poster

NICORE™ ECP

ECP Clinical Considerations

The ScottCare NICORE ECP system provides medical professionals with an opportunity to improve the quality of life of many cardiac patients who have exhausted other options.

Indications

ECP is indicated for use with:

  • Stable and Unstable Angina Pectoris
  • Congestive Heart Failure
  • Acute Myocardial Infarction
  • Cardiogenic Shock

Precautions

Prior to undergoing ECP therapy, patients should be screened for the following, and medical judgment exercised in deciding whether any of these conditions prevent them from receiving treatment:

  • Cardiac catheterization within one to two weeks
  • Uncontrolled arrhythmias
  • Aortic insufficiency which could prevent diastolic augmentation
  • Presence of abdominal aortic aneurysm
  • Severe pulmonary disease
  • Pacemakers in general
  • Congenital heart defects
  • Limiting peripheral vascular disease (PVD) and/or phlebitis. Severe PVD with reduced vascular volume and diminished musculature of the lower extremities
  • Severe hypertension (>180/110mmhg), or heart rate <35 or > 120 bpm
  • Bleeding diathesis
  • Pregnancy

Diagnostic Screening Procedures

  • Doppler Echocardiogram
  • Abdominal Ultrasound
  • Duplex Vascular Ultrasound
  • Pre- and Post-ECP Nuclear Stress Test